Vedanta Research

Advancing
Understanding
in Healthcare

 

Migraine Medical Meeting Presentations


2016

Buse DC, Powers SW, Gelfand AA, VanderPluym J, Fanning KM, Reed ML, Adam AM, Lipton RB. Adolescent Perspectives on the Burden of their Parent’s Migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study. Presented at the 5th European Headache and Migraine Trust International Congress, Glasgow, Scotland, UK, September 15-18, 2016.

Lipton RB, Chu MK, Seng EK, Reed ML, Fanning KM, Adams AM, Buse DC. The Effect of Psychiatric Symptoms on Headache?Related Disability in Migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Presented at the 5th European Headache and Migraine Trust International Congress, Glasgow, Scotland, UK, September 15-18, 2016.

Scher AI, Want SJ, Katsarava Z, Buse DC, Fanning KM, Adams AM, Lipton RB. Epidemiology of Migraine in Men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Presented at the 5th European Headache and Migraine Trust International Congress, Glasgow, Scotland, UK, September 15-18, 2016.

Munjal S, Reed ML, Buse DC, Bennett A, Fanning KM, Lipton RB. Predictors of Inadequate 24-Hour Sustained Response to Medication in Episodic Migraine (EM): Results from AMPP Study. Presented at the 5th European Headache and Migraine Trust International Congress, Glasgow, Scotland, UK, September 15-18, 2016.


2015

Buse DC, Fanning KM, Adams AM, Lipton RB. Parental Perspective of Migraine Burden on Children: Results from the CaMEO Study.  Presented at DHCREF, Lake Buena Vista, FL, July 16-19, 2015. 

Scher AI, Adams AM, Fanning KM, Lipton RB. Pain Comorbidity and the Transition from Episodic to Chronic Migraine: Results from the CaMEO Study. Presented at the AHS 57th Annual Scientfic Meeting, Washington, DC, June 18-21, 2015.

Lipton RB, Adams AM, Buse DC, Fanning KM, Reed ML. A Comparison of the CaMEO Study and AMPP Study: Demographics and Headache-Related Disability. Presented at AHS, Washington DC, June 18–21, 2015.

Buse DE, Adams AM, Fanning KM, Lipton RB. Impact of Migraine on Migraineur-Partner Relationships: Results From the CaMEO. Presented at the AHS 57th Annual Scientfic Meeting, Washington, DC, June 18-21, 2015.

Buse DC, Fanning KM, Manack-Adams A, Lipton RB. Migraine Burden on Migraineurs and Their Spouses-Domestic Partners: Results From the CaMEO.
Presented at the 17th Congress of the IHC, Valencia, Spain, May 14–17, 2015.

Scher AI, Adams AM, Fanning KM, Lipton RB. Pain Comorbidity and the Transition from Episodic to Chronic Migraine: Results from the CaMEO Study. Presented at the 17th Congress of the IHC, Valencia, Spain, May 14–17, 2015.

Buse DC, Dodick DW, Adams AM. Migraineur Perception Regarding Family Burden From CM: Results of the CaMEO Study. Presented at the 67th AAN, Washington, DC, April 18–25, 2015.

Dodick DW, Lipton RB, Fanning KM, Serrano D, Reed ML, Adams AM, Holden A. Effects of Demographic and Socioeconomic Characteristics on Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the CaMEO. Presented at the 67th AAN, Washington, DC , April 18–25, 2015.

Scher AI, Adams AM, Fanning KM, Lipton RB. Pain Comorbidity and the Transition from Episodic to Chronic Migraine: Results from the CaMEO Study. Presented at the 67th AAN, Washington, DC , April 18–25, 2015.


2014

Buse DC, Dodick DW, Adams AM. Migraineur Perception Regarding Family Burden From CM: Results of the CaMEO Study. Presented at the 4th EHMTIC, Copenhagen, Denmark, September 18–21, 2014.

Lipton RB, Serrano D, Adams AM, Buse DC, Scher AI. Trajectories of Headache Days Over One Year (5 Waves) in Chronic and Episodic Migraineurs Participating in the CaMEO Study. Presented at the 4th EHMTIC, Copenhagen, Denmark, September 18–21, 2014.

Buse DC, Dodick DW, Serrano D, Adams AM. Family Burden of Chronic Migraine to the Migraineur: Results of the CaMEO. Presented at the National Conference on Pain (PAINWeek), Las Vegas, NV, September 2–6, 2014.

Dodick DW, Lipton RB, Fanning KM, Serrano D, Reed ML, Adams AM, Holden A. Effects of Demographic and Socioeconomic Characteristics on Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the CaMEO. Presented at the National Conference on Pain (PAINWeek), Las Vegas, NV, September 2–6, 2014.

Lipton RB, Serrano D, Buse DC, and the ID-CM Study Team. Development and Validation of a Screening Tool to Identify CM.  Presented at the PAINWeek National Conference, Las Vegas, NV, September 2-6, 2014.

Dodick DW, Lipton RB, Buse DC, Reed ML, Fanning KM, Adams AM, Holden A. Effects of Demographic and Socioeconomic Characteristics on Barriers to CM Consultation, Diagnosis, and Treatment: Results from the CaMEO Study.  PAINWeek National Conference, Las Vegas, NV,  September 2-6, 2014.

Buse DC, Dodick DW, Serrano D, Adams AM. Family Burden of Chronic Migraine to the Migraineur: Results of the CaMEO. resented at the DHCREF Headache Update, Lake Buena Vista, FL, July 17–20, 2014.

Dodick DW, Lipton RB, Fanning KM, Serrano D, Reed ML, Adams AM, Holden A. Effects of Demographic and Socioeconomic Characteristics on Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the CaMEO. Presented at the DHCREF Headache Update, Lake Buena Vista, FL, July 17–20, 2014.

Buse DC, Adams AM, Fanning KM, Lipton RB. Impact of Migraine on Migraineur-Partner Relationships: Results From the CaMEO. Presented at the DHCREF Headache Update, Lake Buena Vista, FL, July 16–19, 2014.

Lipton RB, Adams AM, Buse DC, Fanning KM, Reed ML. A Comparison of the CaMEO Study and AMPP Study: Demographics and Headache-Related Disability. Presented at the DHCREF Headache Update, Lake Buena Vista, FL, July 16–19, 2014.

Buse DC, Dodick DW, Serrano D, Adams AM. Family Burden of Chronic Migraine to the Migraineur: Results of the CaMEO. Presented at the American Headache Society 2014 Annual Meeting, Los Angeles, CA, June 26–29, 2014.

Dodick DW, Lipton RB, Fanning KM, Serrano D, Reed ML, Adams AM, Holden A. Effects of Demographic and Socioeconomic Characteristics on Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the CaMEO. Presented at the American Headache Society 2014 Annual Meeting, Los Angeles, CA, June 26–29, 2014.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Adams AM. Barriers to Chronic Migraine Care: Results of the CaMEO Study.  Presented at the American Association of Nurse Practitioners Annual Meeting (AANP), Nashville, TN, June 17–22, 2014.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Adams AM. Barriers to Chronic Migraine Care: Results of the CaMEO. Presented at the AANP, Nashville, TN, June 17–22, 2014.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Adams AM. Barriers to Chronic Migraine Care: Results of the CaMEO. Presented at the AAN, Philadelphia, PA. April 26–May 3, 2014.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Adams AM. Barriers to Chronic Migraine Care: Results of the CaMEO. Presented at the AAN, Philadelphia, PA. April 26–May 3, 2014.


2013

Lipton RB, Serrano D, Buse DC, Fanning KM, Adams AM, Reed ML.  Sociodemographic, Disability, and Employment Differences Between Persons With CM and EM. Presented at the XXI World Congress of Neurology, Vienna, Austria, September 21–26, 2013.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Adams AM. Barriers to Chronic Migraine Care: Results of the CaMEO. Presented at DHCREF, Lake Buena Vista, FL, July 11–14, 2013.

Lipton RB, Serrano D, Buse DC, Fanning KM, Manack AN, Reed ML. Sociodemographic, Disability, and Employment Differences Between Persons With CM and EM: Results of the CaMEO. Presented at DHCREF, Lake Buena Vista, FL, July 11–14, 2013.

Manack AN, Reed ML, Marske V, Serrano D, Fanning KM, Cunanan CM, Buse DC, Lipton RB. CaMEO Study: Design, Methodology, and Baseline Cohort Characteristics. Presented at DHCREF, Lake Buena Vista, FL, July 11–14, 2013.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Manack AN. Barriers to Chronic Migraine Care: Results of the CaMEO. Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27–30, 2013. 

Lipton RB, Serrano D, Pavlovic JM, Manack AN, Turkel CC, Reed ML. Improving the Classification of Migraine Subtypes - An Empirical Approach Based on Factor Mixture Models.  Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Lipton RB, Buse DC, Serrano D, Sollars CM, Pavlovic JM, Grosberg BM, Reed ML. Defining the Border-Zone Between Episodic Migraine and Chronic Migraine: Sociodemographics and Headache-related Disability in the US Population. Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Lipton RB, Serrano D, Buse DC, Fanning KM, Manack AM, Reed ML. Sociodemographic, Disability, and Employment Differences Between Persons With CM and EM. Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27–30, 2013.

Adams AM, Reed ML, Marske V, Serrano D, Fanning KM, Cunanan CM, Buse DC, Lipton RB. CaMEo Study - Design, Methodology, and Baseline Cohort Characteristics. Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27–30, 2013.

Buse DC, Serrano D, Reed ML, Pavlovic JM, Sollars CM, Issa SI, Lipton RB. Defining the Border-Zone Between Episodic Migraine and Chronic Migraine: Psychiatric Comorbidities and Chronic Pain in the US Population.  Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Serrano D, Buse DC, Reed ML, Pavlovic JM, Vollbracht SE, Sollars CM, Lipton RB. Defining the Border-Zone Between Episodic Migraine and Chronic Migraine: Medical Comorbidities in the US Population. Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Lipton RB, Serrano D, Buse DC, Fanning KM, Manack AN, Reed ML.  Sociodemographic, Disability, and Employment Differences Between Persons With Chronic and Episodic Migraine: Results of the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study. Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Manack AN, Reed ML, Marske V, Serrano D, Fanning KM, Cunanan CM, Buse DC, Lipton RB.  CaMEO (Chronic Migraine Epidemiology & Outcomes) Study: Design, Methodology, and Baseline Cohort Characteristics.  Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Buse DC, Lipton RB, Reed ML, Serrano D, Fanning KM, Manack AN.  Barriers to Chronic Migraine Care: Results of the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study.  Presented at the American Headache Society-International Headache Congress, Boston, MA, June 27-30, 2013.

Lipton RB, Buse DC, Serrano D, Sollars CM, Pavlovic JM, Grosberg BM, Reed ML. Defining the Border-Zone Between Episodic Migraine and Chronic Migraine: Sociodemographics and Headache-related Disability in the US Population. Presented at the American Academy of Neurology Meeting, San Diego, CA, March 16-23, 2013. 

Buse DC, Serrano D, Reed ML, Pavlovic JM, Sollars CM, Issa SI, Lipton RB. Defining the Border-Zone Between Episodic Migraine and Chronic Migraine: Psychiatric Comorbidities and Chronic Pain in the US Population.  Presented at the American Academy of Neurology Meeting, San Diego, CA, March 16-23, 2013. 

Serrano D, Buse DC, Reed ML, Pavlovic JM, Vollbracht SE, Sollars CM, Lipton RB. Defining the Border-Zone Between Episodic Migraine and Chronic Migraine: Medical Comorbidities in the US Population. Presented at the American Academy of Neurology Meeting, San Diego, CA, March 16-23, 2013.


2012

Lipton RB, Manack AN, Serrano D, Buse D.  Acute Treatment Optimization for Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the European Headache and Migraine Trust International Congress, London, UK, September 20-23, 2012.

Manack AN, Serrano D, Lipton RB, Buse DC. Rates of Stressful Life Events among Chronic and Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the European Headache and Migraine Trust International Congress, London, UK, September 20-23, 2012.

Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB.  The Relationship of Child Maltreatment with Migraine and Tension-type Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the Diamond Meeting, Orlando, FL, July 12-16, 2012.

Martin VT, Fanning KM, Serrano D, Buse DC, Reed ML, Bernstein JA, Lipton RB.  Chronic Rhinitis is Associated with Headache Frequency and Disability in Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Diamond Meeting, Orlando, FL, July 12-16, 2012.

Manack AN, Serrano D, Lipton RB, Buse DC.  Rates of Stressful Life Events among Chronic and Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Diamond Meeting, Orlando, FL, July 12-16, 2012.

Lipton RB, Manack AN, Serrano D, Buse DC. Acute Treatment Optimization for Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Diamond Meeting, Orlando, FL, July 12-16, 2012.

Buse DC, Serrano D, Kori SH, Cunanan CM, Manack AN, Reed ML, Lipton RB. Switching Vs. Consistent Triptan Treatment and Headache-related Disability: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Diamond Meeting, Orlando, FL, July 12-16, 2012.

Lipton RB, Serrano D, Kori SH, Cunanan CM, Manack AN, Reed ML, Buse DC. Adding Acute Treatments for Patients on Triptans and Headache-related Disability: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Diamond Meeting, Orlando, FL, July 12-16, 2012.

Reed ML, Fanning KM, Buse DC, Lipton RB. Nocturnal Headache and Sleep Disturbance in Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012.

Lipton RB, Manack AN, Serrano D, Buse DC. Acute Treatment Optimization for Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012.

Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB.  The Relationship of Child Maltreatment with Migraine and Tension-type Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012. 

Martin VT, Fanning KM, Serrano D, Buse DC, Reed ML, Bernstein JA, Lipton RB.  Chronic Rhinitis is Associated with Headache Frequency and Disability in Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012.

Lipton RB, Serrano D, Buse DC, Kori SH, Cunanan CM, Papapetropoulos S, Manack AN, Reed ML. Does Augmenting Treatment Improve Headache-related Disability in Patients on Triptans?: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Podium Presentation at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012. 

Manack AN, Serrano D, Turkel CC, Lipton RB, Buse DC.  Rates of Stressful Life Events Among Chronic and Episodic MigraineursResults of the American Migraine Prevalence and Prevention (AMPP) Study.  Podium Presentation at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012. 

Serrano D, Buse DC, Kori SH, Cunanan CM, Papapetropoulos S, Manack AN, Reed ML, Lipton RB. Does Switching Treatment Improve Headache-related Disability in Patients on Triptans?  Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Podium Presentation at the 54th AHS Annual Meeting, Los Angeles, CA, June 21-24, 2012. 

Reed ML, Fanning, KM, Buse DC, Lipton RB.  Frequent Nausea in Episodic Migraine (EM) is Associated with Increased Health Care Utilization and Costs: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 64th AAN Annual Meeting, New Orleans, LA, April 21-28, 2012.

Manack AN, Serrano D, Lipton RB, Buse DC.  Rates of Stressful Life Events among Chronic and Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 64th AAN Annual Meeting, New Orleans, LA, April 21-28, 2012.

Lipton RB, Buse DC, Fanning KM, Reed ML. The Impact of Persistent Nausea in Persons with Migraine: Longitudinal Results from the American Migraine Prevalence and  Prevention (AMPP) Study.  Presented at the 64th AAN Annual Meeting, New Orleans, LA, April 21-28, 2012.


2011

Lipton RB, Buse DC, Wood GC, Runken MC, Nicholson RA, Stewart WF. Impact of NSAID Use on Likelihood of Developing Chronic Migraine (CM) Among Persons with Episodic Migraine (EM): Results of the American Migraine Prevalence and Prevention Study (AMPP). Neurology, 2001;76(S4):A180. Presented at the 63rd AAN, Honolulu, HI, April 9-16, 2011.


Manack AN, Buse DC, Serrano D, Varon SF, Lipton RB. Medical Consultation Among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the AMPP Study. Neurology, 2011;76(S4):A35. Presented at the 63rd AAN, Honolulu, HI, April 9-16, 2011.


Stewart WF, Sartorius JA, Bruce CA, Buse DC, Lipton RB.  Comparative Burden in Menstrual Migraine Versus Non-Menstrual Migraine. Neurology, 2011;76(S4):A35.  Presented at the 63rd AAN, Honolulu, HI, April 9-16, 2011.


Buse DC, Pearlman SH, Serrano D, Ng-Mak DS, Reed ML, Lipton RB.  Rates of Opioid Use and Dependence by Sociodemographics, Medical and Psychiatric Comorbidities, and Headache-related Disability Among Persons with Episodic Migraine (EM) in the US population. Headache, 2011;51(S1):28. Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011.


Buse DC, Reed ML, Fanning KM, Lipton RB. Frequent Nausea in Episodic Migraine (EM) is Common and Associated with Increased Burden.  Headache, 2011;51(S1):33. Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011.


Buse DC, Serrano D, Pearlman SH, Ng-Mak DS, Reed ML, Lipton RB. Examination of Unmet Treatment Needs Among Persons with Episodic Migraine (EM): Results of the American Migraine Prevalence and Prevention Study (AMPP). Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011.


Lipton RB, Reed ML, Serrano D, Ng-Mak DS, Pearlman SH, Buse DC. Healthcare Resource Utilization and Associated Costs by Opioid Use and Dependence Status Among Persons with Episodic Migraine (EM) in the US Population. Headache, 2011;51(S1):31-32. Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011.


Lipton RB, Reed ML, Fanning KM, Buse DC. Relationship Between High Frequency Nausea and Treatment Satisfaction in Episodic Migraine.  Headache, 2011;51(S1):32. Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011.


Manack AN, Buse DC, Serrano D, Reed ML, Turkel CC, Lipton RB. Medical Consultation and Headache-impact Among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 2011;51(S1):33. Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011.


Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB.  Prevalence of Chronic Migraine (CM), Headache-related Disability and Sociodemographic Factors in the US Population.  Headache, 2011;51(S1):28. Presented at the 53rd Annual Scientific Meeting of the AHS, Washington, DC, June 2-5, 2011


Buse DC, Reed ML, Manack AN, Fanning K, Serrano D, Turkel CC, Lipton RB.  Prevalence of Chronic Migraine (CM), Headache-Related Disability and Sociodemographic Factors in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 15th Congress of the International Headache Society, Berlin, Germany, June 23-26, 2011.


Buse DC, Reed ML, Serrano D, Ng-Mak DS, Pearlman SH, Lipton RB.  Rates of Opioid Use, Dependence, Sociodemographics, Medical and Psychiatric Comorbidities, and Headache-Related Disability among Persons with Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study.  Presented at the 15th Congress of the International Headache Society, Berlin, Germany, June 23-26, 2011.


Buse DC, Reed ML, Fanning KM, Lipton RB.  Relationship Between High Frequency Nausea, Headache Symptomology, and Treatment Satisfaction in Episodic Migraine (EM): Results of the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the 15th Congress of the International Headache Society, Berlin, Germany, June 23-26, 2011.


Lipton RB, Reed ML, Fanning KM, Buse DC.  Frequent Nausea in Episodic Migraine (EM) is Common and Associated with Increased Burden: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 15th Congress of the International Headache Society, Berlin, Germany, June 23-26, 2011.


Lipton RB, Reed ML, Serrano D, Ng-Mak DS, Pearlman SH, Buse DC.  Health Resource-Utilization (HRU) and Associated Costs by Opioid Use and Dependence Among Episodic Migraine (EM): Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 15th Congress of the International Headache Society, Berlin, Germany, June 23-26, 2011.


Manack AN, Buse DC, Serrano D, Varon SF, Turkel CC, Lipton RB.  Medical Consultation and Headache-Impact (HIT-6) among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the 15th Congress of the International Headache Society, Berlin, Germany, June 23-26, 2011.

 

Buse DC, Reed ML, Fanning KM, Lipton RB. Frequent Nausea in Episodic Migraine (EM) is Common and Associated with Increased Burden: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.


Buse DC, Serrano D, Ng-Mak DS, Pearlman SH, Reed ML, Lipton RB.  Rates of Opioid Use and Dependence by Sociodemographics, Medical and Psychiatric Comorbidities, and Headache-related Disability Among Persons with Episodic Migraine (EM) in the US Population. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.


Lipton RB, Reed ML, Serrano D, Ng-Mak DS, Pearlman SH, Buse DC. Healthcare Resource Utilization and Associated Costs by Opioid Use and Dependence Status Among Persons with Episodic Migraine (EM) in the US Population. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.


Lipton RB, Reed ML, Fanning KM, Buse DC. Relationship Between High Frequency Nausea and Treatment Satisfaction in Episodic Migraine. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.


Manack AN, Buse DC, Serrano D, Varon SF, Turkel CC, Lipton RB.  Medical Consultation and Headache-Impact among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.


Reed ML, Buse DC, Manack AN, Fanning K, Serrano D, Turkel CC, Lipton RB.  Prevalence of Chronic Migraine (CM), Headache-related Disability and Sociodemographic Factors in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.


Stewart WF, Sartorius JA, Bruce CA, Buse DC, Lipton RB.  Comparative Burden in Menstrual Migraine Versus Non-Menstrual Migraine. Presented at the Diamond Headache Update Meeting, July 14-17, 2011.

 

Buse DC, Reed ML, Fanning K, Manack AN, Serrano D, Turkel CC, Lipton RB.  Prevalence of Chronic Migraine (CM), Headache-related Disability and Sociodemographic Factors in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Academy of Pain Management (AAPM) 22nd Annual Clinical Meeting, Las Vegas, NV, September 20-23, 2011.


Manack AN, Buse DC, Serrano D, Turkel CC, Lipton RB. Rates and Predictors of Remission from Chronic Migraine (CM) to Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Academy of Pain Management (AAPM) 22nd Annual Clinical Meeting, Las Vegas, NV, September 20-23, 2011.

 

Buse DC, Pearlman SH, SErrano D, Ng-Mak DS, Reed ML, Lipton RB. Rates of Opioid Use and Dependence by Sociodemographics, Medical and Psychiatric Comorbidities, and Headache-related Disability Among Persons with Episodic Migraine (EM) in the US Population: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Buse DC, Reed ML, Fanning KM, Lipton RB.  Frequent Nausea in Episodic Migraine (EM) is Common and Associated with Increased Burden: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Buse DC, Reed ML, Fanning K, Manack AN, Serrano D, Turkel CC, Lipton RB.  Prevalence of Chronic Migraine (CM), Headache-related Disability and Sociodemographic Factors in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Buse DC, Serrano D, Pearlman SH, Ng-Mak DS, Reed ML, Lipton RB. Examination of Unmet Treatment Needs Among Persons with Episodic Migraine (EM): Results of the American Migraine Prevalence and Prevention Study (AMPP). Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Lipton RB, Reed ML, Serrano D, Ng-Mak DS, Pearlman SH, Buse DC. Healthcare Resource Utilization and Associated Costs by Opioid Use and Dependence Status Among Persons with Episodic Migraine (EM) in the US Population: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Lipton RB, Reed ML, Fanning KM, Buse DC.. Relationship Between High Frequency Nausea and Treatment Satisfaction in Episodic Migraine. Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Manack AN, Buse DC, Serrano D, Reed ML, Turkel CC, Lipton RB. Medical Consultation and Impact Assessments Among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Neurological Association’s 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Reed ML, Buse DC, Manack AN, Fanning K, Serrano D, Turkel CC, Lipton RB.  Prevalence of Chronic Migraine (CM), Headache-related Disability and Sociodemographic Factors in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Neurological Association's 136th Annual Meeting, San Diego, CA, September 25-27, 2011.


Lipton RB, Buse DC, Fanning KM, Reed ML. Frequent Nausea in Episodic Migraine (EM) is Associated with Increased Health Care Utilization and Costs: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Academy of Managed Care Pharmacy Meeting, Atlanta, GA, October 19-21, 2011.


2010 

Lipton RB, Buse DC, Serrano D, Golden W, Bigal ME.  Acute Medication Use Patterns in Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP). Presented at the Diamond Meeting, Scottsdale, AZ, February 8-10, 2010. 

Lipton RB, Manack AN, Buse DC, Serrano D, Turkel CC. Disability Impact Upon Remission from Chronic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Presented at the Diamond Meeting, Scottsdale, AZ, February 8-10, 2010.

Ashina S, Buse DC, Manack AN, et al.  Depression: A Risk Factor for Migraine Chronification: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Neurology, 2010;74(S2):A113.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 13, 2010.

Buse DC, Steiner TJ, Serrano D, et al. The Headache Under-Response to Treatment (HURT) Index: An Instrument Developed by the “Lifting the Burden” Campaign to Improve Management of Headache, Especially in Primary Care.  Neurology, 2010;74(S2):A323.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 14, 2010. 

Golden W, Bigal ME, Yu J, et. al.  Acute Treatment of Migraine in Patients with Cardiovascular Disease or Risk Factors.  Neurology, 2010;74(S2):A581.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 15, 2010. 

Lipton RB, Buse DC, Serrano D, Golden W, Chen YT, Bigal ME.  Acute Medication Use Patterns in Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Neurology, 2010;74(S2):A573-574.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 15, 2010. 
 

Ashina S, Buse DC, Bigal ME, et al.  Cutaneous Allodynia – A Predictor of Migraine Chronification: A Longitudinal Population-based Study.  Neurology, 2010;74(S2):A579.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 15, 2010.

Bigal M, Golden W, Buse DC, Chen YT, Lipton RB.  Triptan Use as a Function of Cardiovascular Risk: A population-based Study.  Neurology, 2010;74(S2):A582.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 15, 2010.

Manack AN, Buse DC, Serrano D Turkel CC, Lipton RB.  Rates and Predictors of Remission from Chronic Migraine (CM) to Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Neurology, 2010;74(S2):A578.  Presented at the Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 15, 2010.

Ashina S, Buse DC, Maizels M, Serrano D, Turkel CC, Lipton RB.  Self-reported Anxiety as a Risk Factor for Migraine Chronification: Results from The American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the American Headache Society Scientific Meeting, Los Angeles, CA, June 24-27, 2010.

Bezov D, Buse DC, Stewart WF, Sartorius JA, Lipton RB. Gender Differences in Headache-related Disability and Resource Utilization in Episodic and Episodic Probable Migraine: Results from the American Migraine Prevalence and Prevention study (AMPP). Headache, 2010;50(S1):S23-S24. Presented at the 52nd Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 24-27, 2010.

Chu MK, Buse DC, Bigal ME, Serrano D, Lipton RB. Factors Associated with Triptan Use in Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 2010;50(S1);S25-S26. Presented at the 52nd Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 24-27, 2010.

Buse DC, Bezoz D, Stewart WF, Sartorius JA, Lipton RB. Gender Differences in Prevalence and Clinical Symptomology in Episodic and Probable Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 2010;50(S1);S37-S38. Presented at the 52nd Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 24-27, 2010.

Manack AN, Buse DC, Serrano D, Turkel CC, Stewart WF, Lipton RB.  Lost Productive Time and Cost Due to Headache in Chronic (CM) and Episodic Migraine (EM): results from the American Migraine Prevalence and Prevention Study (AMPP).  Presented at the American Headache Society Scientific Meeting, Los Angeles, California, June 24-27, 2010.

Serrano D, et. al.  Migraine Symptom Severity Score (MSSS). Presented at the American Headache Society Scientific Meeting, Los Angeles, California, June 24-27, 2010.

Stewart WF, Wood GC, Buse DC, Runken CM, Lipton RB. Longitudinal Change in Headache Days and Work Impact: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2010;50(Suppl 1);S5. Presented at the 52nd Annual Scientific Meeting of the American Headache Society, Los Angeles, California, June 24-27, 2010.

Buse DC, Manack AN, Serrano D, Varon S, Turkel CC, Lipton RB.  Comparison of Headache Impact (Measured by the HIT-6) by Migraine Status: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Presented at the European Headache and Migraine Trust Congress, Nice, France, October 28-31, 2010.

Lipton RB, Manack AN, Serrano D, Varon S, Turkel CC, Buse DC.  Predictors of Headache Impact (HIT-6) by Migraine Status: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Presented at the European Headache and Migraine Trust Congress, Nice, France, October 28-31, 2010.

Manack AN, Buse DC, Serrano D, Turkel CC, Lipton RB.  Rates and Predictors of Remission from Chronic Migraine (CM) to Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Diamond Meeting, Scottsdale, AZ, February 8-10, 2010.

Manack AN, Buse DC, Serrano D, Turkel CC, Lipton RB.  Rates and Predictors of Remission from Chronic Migraine (CM) to Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Cephalalgia, 2009;29:63. Presented at the European Headache and Migraine Trust Congress, Nice, France, October 28-31, 2010.

Manack AN, Buse DC, Serrano D, Turkel CC, Stewart WF, Lipton RB.  Lost Productive Time and Cost Due to Headache in Chronic (CM) and Episodic Migraine (EM): results from the American Migraine Prevalence and Prevention Study (AMPP).  Presented at the European Headache and Migraine Trust Congress, Nice, France, October 28-31, 2010.

Serrano D, Buse DC, Reed ML, Runken CM, Lipton RB.  Migraine True Disease State Estimates (MTDSE): Improving Sensitivity in Migraine Definition and Drug-efficacy Detection. Presented at the European Headache and Migraine Trust Congress, Nice, France, October 28-31, 2010.


2009

Lipton RB, Buse DC, Serrano D, Manack AN, Reed ML, Turkel CC. Differences in Rates of Common Comorbid Medical and Psychiatric Conditions in Chronic and Episodic Migraine Individuals. Platform presentation at the 2009 Diamond Headache Meeting, Scottsdale, AZ, February 9-13, 2009. 

Manack AN, Buse DC, Serrano D, Turkel CC, Reed ML, Lipton, RB. Sociodemographic Differences Between Chronic Migraine and Episodic Migraine. Platform presentation at the 2009 Diamond Headache Meeting, Scottsdale, AZ, February 9-13, 2009.

Buse DC, Serrano D, Manack AN, Grosberg BM, Turkel CC, Reed ML, Lipton, RB. Comparison of Headache Related Disability, Treatment, and Healthcare Utilization between Chronic Migraine (CM) and Episodic Migraine (EM) Populations: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Platform presentation at the 2009 Diamond Headache Meeting, Scottsdale, AZ, February 9-13, 2009.

Lipton RB, Manack AM, Buse DC, Serrano D, Reed M, Chiao E, Turkel CC. Cost of Healthcare Utilization for Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the American Academy of Neurology,  Seattle, WA, April 25-May 2, 2009. 

Munakata J, Serrano D, Klingman D, Hazard E, Rupnow MFT, Tierce J, Reed M, Stewart WF, Lipton RB.  Relation of Headache Frequency to Healthcare Utilization, Work Productivity, and Total Costs: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the ISPOR 14th Annual International Meeting, Orlando, FL, May 16-20, 2009.

Buse DC, Serrano D, Manack AN, Grosberg BM, Turkel CC, Reed ML, Lipton, RB. Comparison of Headache Related Disability, Lost Productive Time, and Healthcare Utilization between Chronic Migraine (CM) and Episodic Migraine (EM) Populations: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Platform presentation at the 2009 Diamond Headache Meeting, Lake Buena Vista, FL, July 13-18, 2009.

Lipton RB, Buse DC, Serrano D, Manack AN, Turkel CC. Differences in Sociodemographic and Comorbidity Profiles in Chronic and Episodic Migraine Individuals: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Platform presentation at the Diamond Headache Meeting, Lake Buena Vista, Florida, July 13-18, 2009.

Manack AN, Buse DC, Serrano D, Grosberg B, Turkel CC, Reed ML, Lipton RB. Comparison of Headache Related Disability, and Healthcare Utilization between Chronic Migraine and Episodic Migraine Populations: Results of the American Migraine Prevalence and Prevention Study (AMPP). Podium presention at the Diamond Meeting, Orlando, FL, July 13-18, 2009.

Lipton RB, Manack AN, Buse DC, Serrano D, Reed ML, Chiao E, Turkel CC. Healthcare Costs for Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the 2009 Diamond Headache Meeting, Lake Buena Vista, F, July 13-18, 2009.

Ashina S, Buse DC, Bigal ME, Serrano D, Reed ML, Lipton RB.  Cutaneous Allodynia – A predictor of Migraine Chronification: A Longitudinal Population-based Study.  Cephalalgia, 2009;29:58-59.  Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009.

Lipton RB, Manack AN, Buse DC, Serrano D, Turkel CC. Disability Impact Upon Remission from Chronic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Cephalalgia, 2009;29:72. Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009. 

Manack AN, Buse DC, Serrano D, Turkel CC, Lipton RB. Rates and Predictors of Remission from Chronic Migraine to Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Cephalalgia, 2009;29:63. Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009.

Stewart WF, Woods GC, Manack AN, Buse DC, Varon SF, Scher AI, Serrano D, Reed ML, Lipton RB. Employment and Work Impact of Headache Among Episodic and Chronic Migraine Sufferers: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Cephalalgia, 2009;29:57-58. Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009.


Buse DC, Bigal ME, Serrano D, Golden W, Lipton RB.  Triptan Use Patterns Among Migraine Sufferers: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Cephalalgia, 2009;29:11. Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009. 

Buse DC, Manack AN, Serrano D, Turkel CC, Lipton RB.  Age-specific Estimates of Lost Time Due to Headache in Chronic Migraine and Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Cephalalgia, 2009;29:61. Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009.

Lipton RB, Buse DC, Serrano D, Golden W, Bigal ME. Acute Medication Use Patterns in Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP).  Cephalalgia, 2009;29:17. Presented at the 14th Congress of the International Headache Society, Philadelphia, PA, September 10-13, 2009.


2008

Bigal ME, Serrano D, Buse DC, Lipton RB. Excessive Use of Analgesics is Associated with the Development of Transformed Migraine in the Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the National Headache Foundation 2008 Meeting. 

Buse DC, Serrano D, Bigal ME, Rupnow MFT, Reed ML, Biondi DM, Lipton RB. The Relationship Between Ictal and Interictal Burden in the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the National Headache Foundation 2008 Meeting.

Bigal ME, Reed ML, Serrano D, et al.  Excessive Use of Barbiturates and Opioids as Risk Factors for Chronic Migraine - A Population Study.   Neurology, 2008;70(1):A404.  Presented at the Annual Meeting of the American Academy of Neurology, Chicago, IL, April 12-19, 2008.

Boruchow S, Lipton, RB, Bigal ME.  The Acute Treatment of Episodic and Chronic Migraine in the United States.  Neurology 70(1):A152, 2008.  Presented at the Annual Meeting of the American Academy of Neurology, Chicago, IL, April 12-19, 2008.

Munakata J, Hazard E, Serrano D, et. al.  Economic Burden of Transformed Migraine (TM): Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Neurology, 2008;70(1):A347.  Presented at the Annual Meeting of the American Academy of Neurology, Chicago, IL, April 12-19, 2008.

Bigal ME, Buse DC, Manack AN, Serrano D, Biondi DM, Lipton RB.  Sociodemographic differences Between Chronic Migraine and Episodic Migraine.  Headache, 2008;48(S1):S17.  Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008. 

Bigal ME, Serrano D, Scher A, et. al.  Acute Migraine Medications and Evolution from Episodic to Chronic Migraine: A Longitudinal Population-based Study.  Headache, 2008;48(S1):S3.  Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008.

Buse DC, Manack AN, Serrano D, Grosbert BM, Bigal ME, Biondi DM, Lipton RB.  Summary of Disability, Treatment and Healthcare Utilization Differences Between Chronic Migraine and Episodic Migraine Populations.  Headache, 2008;48(S1):S18.  Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008.

Buse DC, Serrano D, Rupnow MFT, et, al.  Interictal Burden Among Individuals with Severe Headache: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2008;48(S1):S18.  Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008.

Lipton RB, Serrano D, Buse DC, et. al.  The Migraine Prevention Questionnaire (MPQ-5): Development, Psychometric Testing and Validation. Headache, 2008;48(S1):S65.  Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008. 

Lipton RB, Buse DC, Serrano D, et. al.  Differences in Rates of Common Comorbid Medical and Psychiatric Conditions in Chronic and Episodic Migraine Individuals.  Headache, 2008;48(S1):S4.  Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008.

Lipton RB, Serrano D, Buse DC, Bigal ME, Rupnow MFT, Biondi D. The Migraine Prevention Questionnaire (MPQ-5): Development, Psychometric Testing and Validation. Headache, 2008;48(S1):S65. Presented at the 50th Annual Scientific Meeting of the American Headache Society, Boston, MA, June 26-29, 2008.

Manack AN, Serrano D, Buse DC, Chiao E, Lipton RB. Comparison of Healthcare Resource Utilization, Associated Costs, and Lost Productivity Among Chronic Migraine and Episodic Migraine Populations: Results From the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the Association of Managed Care Pharmacy 2008 Scientific Meeting, Kansas City, MO, October 15-18, 2008. 


2007

Buse DC, Bigal ME, Rupnow MFT, Reed ML, Serrano D, Hulihan JF, Lipton RB. Development and Validation of the Migraine Interictal Burden Scale (MIBS): A Self-Administered Instrument for Measuring The Burden Of Migraine Between Attacks. Presented at the National Headache Federation, 4th Annual Headache Research Summit, Palm Springs, CA, February 14, 2007. 

Ashina S, Bigal ME, Burstein R, Silberstein S, Reed ML, Lipton RB.  Allodynia in Headache Sufferers: A Population Study.  Neurology, 2007;68(S1):A195.  Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Bigal ME, Lipton RB, Winner P, Reed ML, Diamond S, Stewart WF. Migraine In Adolescents - The American Migraine Prevalence And Prevention (AMPP) Study.   Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Bigal ME, Lipton RB, Winner P, Reed ML, Stewart WB.  Migraine Prevalence Varies with Family Income in Adolescents in the United States. Neurology, 2007;68(S1):A180-A181.    Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Buse DC, Bigal M, Diamond S, Diamond M, Reed ML, Lipton RB.  Results of the American Migraine Prevalence and Prevention (AMPP) Study: Comorbidity of Depression, Obesity, Disability and Headache.  Neurology, 2007;68(S1):A264.    Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Li Z, Bigal M, Lipton RB.  Treatment of Probable Migraine by Age and Demographics: A Population Study.  Neurology, 2007;68(S1):A369.    Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Buse DC, Bigal ME, Rupnow M, Reed ML, Serrano D, Lipton RB.  Development and Validation of the Migraine Interictal Burden Scale (MIBS): a Self-administered Instrument for Measuring the Burden of Migraine Between Attacks.  Neurology, 2007;68(S1):A89.    Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Ashina S, Bigal ME, Burstein R, Silberstein S, Reed ML, Lipton RB.  Predictors of Allodynia in Patients with Migraine: A Population Study.  Neurology, 2007;68(S1):A263.  Presented at the Annual Meeting of the American Academy of Neurology, Boston, MA, April 28-May 5, 2007.

Friedman BW, Reed ML, Serrano D, Diamond M, Lipton RB.  Frequency of Emergency Department or Urgent Care Use: Results from the American Migraine Prevalence and Prevention Study. Headache, 2007;47(5):745-746. Presented at the Society for Academic Emergency Medicine Annual Meeting, Chicago, IL, May, 2007.

Munakata J, Hazard E, Tierce J, Rupnow M, Serrano D, Reed ML, Lipton RB. Association of Long-term Migraine Preventive Medication Use and Resource Utilization/Productivity Loss: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Presented at the International Society For Pharmacoeconomics and Outcomes Research Meeting, Arlington, VA, May 2007.

Bigal ME, Lipton RB, Winner P, et. al.  Clinical Markers of Cardiovascular Risk in Migraine: Association with Weight Change.  Headache, 2007;47(5):791. Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Bigal ME, Lipton RB, Buse DC, Ashina S, Reed ML, Serrano D.  Prevalence and Characteristics of Allodynia in Headache Sufferers: Results from the American Prevalence and Prevention (AMPP) Study. Headache, 2007;47(5):782-783. Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Bigal ME, Tsang A, Reed ML, Serrano D, Loder E, Lipton RB.  Body Mass Index and Episodic Headaches: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2007;47(5):761.  Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Buse DC, Bigal ME, Reed ML, Diamond S, Diamond M, Lipton RB.  Relationship of Depression and Headache Type, Disability, and Body Mass Index: Results of the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2007;47(5):745.  Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007. 

Buse DC, Bigal ME, Reed ML, Serrano D, Lipton RB.  Allodynia Varies with the Presence of Depression for All Types of Headache: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 2007;47(5):777. Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007. 

Friedman BW, Reed ML, Serrano D, Diamond M, Lipton RB.  Frequency of Emergency Department or Urgent Care Use: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 2007;47(5):745-746.  Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Li Z., Lipton RB, Bigal ME.  Migraine: Treatment and Demographics.  Headache, 2007;47(5):779-780. Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Lipton RB, Serrano D, Buse DC, et al.  The Migraine Prevention Questionnaire (MPQ): Development and Validation.  Headache, 2007;47(5):770-771.  Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Lipton RB. Lessons from the American Migraine Prevalence and Prevention (AMPP) Study.  Invited Lecturer, 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007. 

Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Stewart WF,  Serrano D. Allodynia in a Population Sample of Migraine Sufferers. Presented at the 49th Annual Scientific Meeting of the American Headache Society, Chicago, IL, June 7-11, 2007.

Bigal ME, Lipton RB, Winner P, Reed ML, Diamond S, Stewart WF, on behalf of the AMPP Advisory Group.  Migraine in Adolescents: Association with Socioeconomic Status and Family History.  Neurology, 2007;69:16-25. Presented at the 13th Congress of the International Headache Society, Stockholm, Sweden, June 28-July 1, 2007.

Buse DC, Bigal ME, Rupnow MFT, Reed ML, Serrano D, Biondi DM, Hulihan JF, Lipton RB. The Migraine Interictal Burden Scale (MIBS):  A New Instrument to Measure Global Burden of Migraine between Attacks. Presented at the 13th Congress of the International Headache Society, Stockholm, Sweden, June 28-July 1, 2007. 

Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Stewart WF, Serrano D. Allodynia in a Population Sample of Migraine Sufferers. Presented at the 13th Congress of the International Headache Society, Stockholm, Sweden, June 28-July 1, 2007. 


2006

Silberstein S, Diamond S, Loder E, Reed ML, Bigal ME, Lipton RB.  Candidates for Preventive Migraine Therapy: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Presented at the American Academy of Neurology, San Diego, CA, April 1-8, 2006.

Winner P, Diamond M, Freitag F, Reed ML, Bigal M, Lipton RB.  Migraine Prevalence, Disability and Prevention Need in a Community Sample of Adolescents: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2006;46(5):834.  Presented at the American Academy of Neurology, San Diego, CA, April 1-8, 2006.

Bigal ME, Loder E, Silberstein S, Reed ML, Lipton RB.  Preventive Therapy Use and Need in Probable Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2006;46(5):886.  Presented at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 22-25, 2006.

Stewart WF, Diamond S, Reed ML, Bigal M, Lipton RB.  Disability, Depression and Work-related Impairment Among a Community Sample of Migraineurs Who are Candidates for Preventive Therapy: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 2006;46(5):879.  Presented at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 22-25, 2006.

Stewart WF, Reed ML, Bigal ME, Lipton RB.  Lifetime Migraine Incidence: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2006;46(5):870.  Presented at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 22-25, 2006.

Winner P, Diamond M, Freitag F, Reed ML, Bigal M, Lipton RB.  Migraine Prevalence, Disability and Prevention Need in a Community Sample of Adolescents: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2006;46(5):834.  Presented at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 22-25, 2006.

Lipton RB, Stewart WF, Burstein R, et al, on behalf of the AMPP.  Validation of the Allodynia Symptom Checklist (ASC) in a Population Study of Headache Sufferers.  Headache, 2006;46(5):838.  Presented at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles, CA, June 22-25, 2006.


Buse DC, Bigal ME, Reed ML, Diamond S, Diamond ML, Lipton RB.  Prevalence of Depression Varies with Headache Type, Disability, and Body Mass Index: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia, 2006;26:1366. Presented at the Migraine Trust Meeting, London, England, September 18-20, 2006.

Lipton RB, Bigal ME, Winner PW, Diamond S, Reed ML. Epidemiology, Burden and Patterns of Treatment of Adolescents in the United States.  Presented at the Migraine Trust Meeting, London, England, September 18-20, 2006.


2005

Lipton RB, Diamond M, Freitag FG, Bigal ME, Stewart WF, Reed ML.  Migraine Prevention Patterns in a Community Sample: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2005;45:792.  Presented at the 47th Annual Scientific Meeting of the American Headache Society, Philadelphia, PA, June 23-25, 2005.

Silberstein S, Diamond S, Loder E, Lipton RB.  Prevalence of Migraine Sufferers Who are Candidates for Preventive Therapy: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Headache, 2005;45:770-771.  Presented at the 47th Annual Scientific Meeting of the American Headache Society, Philadelphia, PA, June 23-25, 2005.